Prednisolone Acetate 1% Oph Susp
Prednisolone Acetate 1% Oph Susp is a pharmaceutical drug with 10 clinical trials. Currently 1 active trials ongoing. Historical success rate of 85.7%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
9
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
75.0%
6 of 8 finished
25.0%
2 ended early
1
trials recruiting
10
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Dextenza vs Prednisolone Acetate After Cataract Surgery for Patients With Diabetes
Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery
Dextenza in the Post-op Management of Vitreoretinal Surgeries
Prospective Study on DEXTENZA® Safety And Efficacy Following Concomitant MIGS and Cataract Surgery
Effect of Intraoperative Dexamethasone on Post-op Dry Eye
Clinical Trials (10)
Dextenza vs Prednisolone Acetate After Cataract Surgery for Patients With Diabetes
Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery
Dextenza in the Post-op Management of Vitreoretinal Surgeries
Prospective Study on DEXTENZA® Safety And Efficacy Following Concomitant MIGS and Cataract Surgery
Effect of Intraoperative Dexamethasone on Post-op Dry Eye
Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Corneal Transplant Surgery
DEXTENZA Compared to Topical Steroid Therapy Prior to Cataract Surgery in Patients Who Receive Premium Intraocular Lenses
The Effectiveness and Safety of FK-506 for the Treatment of Posner-Schlossman Syndrome
Loteprednol vs. Prednisolone and Fluorometholone
A Study to Evaluate the Safety and Efficacy of Lotemax Ophthalmic Suspension 0.5%
All 10 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 10